Skip to main content
Top
Published in: Abdominal Radiology 3/2019

01-03-2019 | Review

Abdominal and pelvic imaging findings associated with sex hormone abnormalities

Authors: Nicole Kurzbard-Roach, Priyanka Jha, Liina Poder, Christine Menias

Published in: Abdominal Radiology | Issue 3/2019

Login to get access

Abstract

Hormones are substances that serve as chemical communication between cells. They are unique biological molecules that affect multiple organ systems and play a key role in maintaining homoeostasis. In this role, they are usually produced from a single organ and have defined target organs. However, hormones can affect non-target organs as well. As such, biochemical and hormonal abnormalities can be associated with anatomic changes in multiple target as well as non-target organs. Hormone-related changes may take the form of an organ parenchymal abnormality, benign neoplasm, or even malignancy. Given the multifocal action of hormones, the observed imaging findings may be remote from the site of production, and may actually be multi-organ in nature. Anatomic findings related to hormone level abnormalities and/or laboratory biomarker changes may be identified with imaging. The purpose of this image-rich review is to sensitize radiologists to imaging findings in the abdomen and pelvis that may occur in the context of hormone abnormalities, focusing primarily on sex hormones and their influence on these organs.
Literature
1.
go back to reference Conn P.M (2005). Introduction to Endocrinology. In: Melmed S., Conn P.M. (eds) Endocrinology. Humana Press: Totowa. Conn P.M (2005). Introduction to Endocrinology. In: Melmed S., Conn P.M. (eds) Endocrinology. Humana Press: Totowa.
3.
4.
go back to reference Onstad MA, Schmandt RE, Lu KH. (2016) Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol; 34: 4225-4230CrossRefPubMedPubMedCentral Onstad MA, Schmandt RE, Lu KH. (2016) Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol; 34: 4225-4230CrossRefPubMedPubMedCentral
5.
go back to reference Harada N, Ota H, Yoshimura N, Katsuyama T, Takagi Y. (1998) Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver. J Clin Endocrinol Metab; 83: 697-702.PubMed Harada N, Ota H, Yoshimura N, Katsuyama T, Takagi Y. (1998) Localized aberrant expression of cytochrome P450 aromatase in primary and metastatic malignant tumors of human liver. J Clin Endocrinol Metab; 83: 697-702.PubMed
6.
go back to reference Wenniger LM, Terpstra V, Beuers U. (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg; 27:24-31.CrossRef Wenniger LM, Terpstra V, Beuers U. (2010) Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg; 27:24-31.CrossRef
7.
go back to reference Kaltenbach TE, Engler P, Kratzer W, et al. (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol; 41:25-32.CrossRefPubMedCentral Kaltenbach TE, Engler P, Kratzer W, et al. (2016) Prevalence of benign focal liver lesions: ultrasound investigation of 45,319 hospital patients. Abdom Radiol; 41:25-32.CrossRefPubMedCentral
10.
go back to reference Grazioli L, Abrosini R, Frittoli B, Grazioli M, Morone M. (2017) Primary benign liver lesions. Eur J Radiol; 95: 378-398.CrossRefPubMed Grazioli L, Abrosini R, Frittoli B, Grazioli M, Morone M. (2017) Primary benign liver lesions. Eur J Radiol; 95: 378-398.CrossRefPubMed
12.
go back to reference Ringe KI, Husarik DB, Sirlin CB, Merkle EM. (2010) Gadoxetate disodium-enhanced MRI of the liver: part I, protocol optimization and lesion appearance in the noncirrhotic liver. Am J Roentgenol; 195:13-28.CrossRef Ringe KI, Husarik DB, Sirlin CB, Merkle EM. (2010) Gadoxetate disodium-enhanced MRI of the liver: part I, protocol optimization and lesion appearance in the noncirrhotic liver. Am J Roentgenol; 195:13-28.CrossRef
13.
go back to reference Grazioli L, Bondioni MP, Haradome H, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology; 262: 520-529.CrossRefPubMed Grazioli L, Bondioni MP, Haradome H, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology; 262: 520-529.CrossRefPubMed
14.
go back to reference Casarella WJ, Knowles DM, Wolff M, Johnson PM. (1976) Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation. Am J Roentgenol; 131:393-402.CrossRef Casarella WJ, Knowles DM, Wolff M, Johnson PM. (1976) Focal nodular hyperplasia and liver cell adenoma: radiologic and pathologic differentiation. Am J Roentgenol; 131:393-402.CrossRef
15.
go back to reference Venkatesh K. (2014) Liver masses: a clinical, radiological, and pathological perspective for: Perspectives in clinical gastroenterology and hepatology. Clin Gastroenterol Hepatol; 12: 1414-1429.CrossRefPubMed Venkatesh K. (2014) Liver masses: a clinical, radiological, and pathological perspective for: Perspectives in clinical gastroenterology and hepatology. Clin Gastroenterol Hepatol; 12: 1414-1429.CrossRefPubMed
16.
go back to reference Virgilio E, Cavallini M. (2018) Managing focal nodular hyperplasia of the liver: surgery or minimally invasive approaches? A review of the preferable treatment options. Anticancer Res; 38: 33-36.CrossRefPubMed Virgilio E, Cavallini M. (2018) Managing focal nodular hyperplasia of the liver: surgery or minimally invasive approaches? A review of the preferable treatment options. Anticancer Res; 38: 33-36.CrossRefPubMed
17.
go back to reference Kuo YH, Wang JH, Lu SN, et al. (2009) Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound; 37: 132-137.CrossRefPubMed Kuo YH, Wang JH, Lu SN, et al. (2009) Natural course of hepatic focal nodular hyperplasia: a long-term follow-up study with sonography. J Clin Ultrasound; 37: 132-137.CrossRefPubMed
18.
go back to reference Agrawal S, Agarwal S, Arnason T, et al. (2015) Management of hepatocellular adenoma: recent advances. Clin Gastroenterol Hepatol; 7:1221-1230CrossRef Agrawal S, Agarwal S, Arnason T, et al. (2015) Management of hepatocellular adenoma: recent advances. Clin Gastroenterol Hepatol; 7:1221-1230CrossRef
19.
go back to reference Stoot J, Coelen R, de Jong MC, Dejong C. (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford); 12:509-522.CrossRef Stoot J, Coelen R, de Jong MC, Dejong C. (2010) Malignant transformation of hepatocellular adenomas into hepatocellular carcinomas: a systematic review including more than 1600 adenoma cases. HPB (Oxford); 12:509-522.CrossRef
20.
go back to reference Grazioli L, Federle M, Brancatelli G, et al. (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics; 21: 877-894.CrossRefPubMed Grazioli L, Federle M, Brancatelli G, et al. (2001) Hepatic adenomas: imaging and pathologic findings. Radiographics; 21: 877-894.CrossRefPubMed
21.
go back to reference Van Aalten SM, Thomeer MGJ, Terkivatan T, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classifications. Radiology; 261:172-181.CrossRefPubMed Van Aalten SM, Thomeer MGJ, Terkivatan T, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classifications. Radiology; 261:172-181.CrossRefPubMed
24.
go back to reference Agarwal S, Fuentes-Orrego JM, Amason T, et al. (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. Am J Roentgenol; 203: W408-414.CrossRef Agarwal S, Fuentes-Orrego JM, Amason T, et al. (2014) Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI. Am J Roentgenol; 203: W408-414.CrossRef
25.
go back to reference Cobey FC, Salem RR. (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg; 187: 181-191.CrossRefPubMed Cobey FC, Salem RR. (2004) A review of liver masses in pregnancy and a proposed algorithm for their diagnosis and management. Am J Surg; 187: 181-191.CrossRefPubMed
26.
go back to reference Thomeer MG, Broker M, Verheij J, et al. (2016) Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol; 9: 898-912.CrossRefPubMedPubMedCentral Thomeer MG, Broker M, Verheij J, et al. (2016) Hepatocellular adenoma: when and how to treat? Update of current evidence. Therap Adv Gastroenterol; 9: 898-912.CrossRefPubMedPubMedCentral
27.
go back to reference Almashhrawi AA, Ahmed KT, Rahman RN, Hammoud GM, Ibdah JA. (2013) Liver diseases in pregnancy: diseases not unique to pregnancy. World J Gastroenterol; 19: 7630-7638.CrossRefPubMedPubMedCentral Almashhrawi AA, Ahmed KT, Rahman RN, Hammoud GM, Ibdah JA. (2013) Liver diseases in pregnancy: diseases not unique to pregnancy. World J Gastroenterol; 19: 7630-7638.CrossRefPubMedPubMedCentral
28.
31.
go back to reference Dilawari J.B., Bambery P., Chawla Y. (1994) Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore);73:21–36.CrossRef Dilawari J.B., Bambery P., Chawla Y. (1994) Hepatic outflow obstruction (Budd-Chiari syndrome). Experience with 177 patients and a review of the literature. Medicine (Baltimore);73:21–36.CrossRef
32.
go back to reference Brancatelli G, Vilgrain V, Federle MP, et al. (2007) Budd-Chiari syndrome: spectrum of imaging findings. Am J Roentgenol; 188: W168-W176.CrossRef Brancatelli G, Vilgrain V, Federle MP, et al. (2007) Budd-Chiari syndrome: spectrum of imaging findings. Am J Roentgenol; 188: W168-W176.CrossRef
33.
go back to reference Ferra H, Behrens G, Lopera J. (2012) Budd-Chiari syndrome. Am J Roentgenol; 199: 737-745.CrossRef Ferra H, Behrens G, Lopera J. (2012) Budd-Chiari syndrome. Am J Roentgenol; 199: 737-745.CrossRef
34.
go back to reference Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology; 210:443–450CrossRefPubMed Vilgrain V, Lewin M, Vons C, et al. (1999) Hepatic nodules in Budd-Chiari syndrome: imaging features. Radiology; 210:443–450CrossRefPubMed
35.
go back to reference Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. (2002) Large regenerative nodules in Budd- Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinico- pathologic correlation. Am J Roentgenol; 178:877–883.CrossRef Brancatelli G, Federle MP, Grazioli L, Golfieri R, Lencioni R. (2002) Large regenerative nodules in Budd- Chiari syndrome and other vascular disorders of the liver: CT and MR imaging findings with clinico- pathologic correlation. Am J Roentgenol; 178:877–883.CrossRef
36.
go back to reference Ruh J, Malago M, Busch Y, et al. (2005) Management of Budd-Chiari syndrome. Dig Dis Sci; 50:540–546CrossRefPubMed Ruh J, Malago M, Busch Y, et al. (2005) Management of Budd-Chiari syndrome. Dig Dis Sci; 50:540–546CrossRefPubMed
37.
go back to reference Jha RC, Khera SS, Kalaria AD. (2018) Portal vein thrombosis: imaging the spectrum of diseases with an emphasis on MRI features. Am J Roentgenol; 211:14-24.CrossRef Jha RC, Khera SS, Kalaria AD. (2018) Portal vein thrombosis: imaging the spectrum of diseases with an emphasis on MRI features. Am J Roentgenol; 211:14-24.CrossRef
38.
go back to reference Davidson KG, Dubinsky TJ. (2003) Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin N Am; 41:769-780.CrossRefPubMed Davidson KG, Dubinsky TJ. (2003) Ultrasonographic evaluation of the endometrium in postmenopausal vaginal bleeding. Radiol Clin N Am; 41:769-780.CrossRefPubMed
39.
go back to reference Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA; 280:1510-1517.CrossRefPubMed Smith-Bindman R, Kerlikowske K, Feldstein VA, et al. (1998) Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA; 280:1510-1517.CrossRefPubMed
40.
go back to reference Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. (2016) Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol; 27:e8.CrossRefPubMed Chandra V, Kim JJ, Benbrook DM, Dwivedi A, Rai R. (2016) Therapeutic options for management of endometrial hyperplasia. J Gynecol Oncol; 27:e8.CrossRefPubMed
41.
go back to reference Freeman SJ, Aly AM, Kataoka MY, et al. (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics; 32:1805-1827.CrossRefPubMed Freeman SJ, Aly AM, Kataoka MY, et al. (2012) The revised FIGO staging system for uterine malignancies: implications for MR imaging. Radiographics; 32:1805-1827.CrossRefPubMed
42.
go back to reference Achiron R, Grisaru D, Golan-Porat N, Lipitz S. (1996) Tamoxifen and the uterus: an old drug tested by new modalities. Ultrasound Obstet Gynecol; 7:374-378.CrossRefPubMed Achiron R, Grisaru D, Golan-Porat N, Lipitz S. (1996) Tamoxifen and the uterus: an old drug tested by new modalities. Ultrasound Obstet Gynecol; 7:374-378.CrossRefPubMed
44.
go back to reference Huo D, Anderson D, Palmer JR, Herbst AL. (2017) Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: update after 40-year follow up. Gynecologic Oncology; 146:566-571.CrossRefPubMed Huo D, Anderson D, Palmer JR, Herbst AL. (2017) Incidence rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix: update after 40-year follow up. Gynecologic Oncology; 146:566-571.CrossRefPubMed
45.
go back to reference Gilles R, Michel G, Chancelier MD, Vanel D, Masselot J. (1993) Case report: clear cell adenocarcinoma of the vagina: MR features. Br J Radiol;66:168-70.CrossRefPubMed Gilles R, Michel G, Chancelier MD, Vanel D, Masselot J. (1993) Case report: clear cell adenocarcinoma of the vagina: MR features. Br J Radiol;66:168-70.CrossRefPubMed
46.
go back to reference Parikh JH, Barton DPJ, Ind TEJ, Sohaib SA. (2008) MR imaging features of vaginal malignancies. Radiographics; 28:49-63.CrossRefPubMed Parikh JH, Barton DPJ, Ind TEJ, Sohaib SA. (2008) MR imaging features of vaginal malignancies. Radiographics; 28:49-63.CrossRefPubMed
47.
go back to reference Williams T, Mortada R, Porter S. (2016) Diagnosis and treatment of polycystic ovary syndrome. Am Fam Phys; 94:106-113. Williams T, Mortada R, Porter S. (2016) Diagnosis and treatment of polycystic ovary syndrome. Am Fam Phys; 94:106-113.
48.
go back to reference Lee TT, Rausch ME. (2012) Polycystic ovarian syndrome: role of imaging in diagnosis. Radiographics; 32: 1643-1657.CrossRefPubMed Lee TT, Rausch ME. (2012) Polycystic ovarian syndrome: role of imaging in diagnosis. Radiographics; 32: 1643-1657.CrossRefPubMed
49.
go back to reference Lujan ME, Chizen DR, Pierson RA. (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Can; 30: 671-679.CrossRefPubMedPubMedCentral Lujan ME, Chizen DR, Pierson RA. (2008) Diagnostic criteria for polycystic ovary syndrome: pitfalls and controversies. J Obstet Gynaecol Can; 30: 671-679.CrossRefPubMedPubMedCentral
51.
go back to reference Fitzgerald S, Divasta A, Gooding H. (2018) An update on PCOS in adolescents. Curr Opin Pediatr; 30:459-465.PubMed Fitzgerald S, Divasta A, Gooding H. (2018) An update on PCOS in adolescents. Curr Opin Pediatr; 30:459-465.PubMed
52.
go back to reference Babagbemi KT, Arleo EK, Asrani AV, Troiano RN. (2013) Emergent complications of assisted reproduction: expecting the unexpected. Radiographics; 33:229-244.CrossRefPubMed Babagbemi KT, Arleo EK, Asrani AV, Troiano RN. (2013) Emergent complications of assisted reproduction: expecting the unexpected. Radiographics; 33:229-244.CrossRefPubMed
53.
go back to reference Lurain JR. (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation, and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol; 203: 531-539.CrossRefPubMed Lurain JR. (2010) Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation, and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole. Am J Obstet Gynecol; 203: 531-539.CrossRefPubMed
54.
go back to reference Lurain JR. (2011) Gestational trophopblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol; 204: 11-18.CrossRefPubMed Lurain JR. (2011) Gestational trophopblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol; 204: 11-18.CrossRefPubMed
55.
go back to reference Shaaban AM, Rezvani M, Haroun RR, et al. (2017) Gestational trophoblastic disease: clinical and imaging features. Radiographics; 37: 681-700.CrossRefPubMed Shaaban AM, Rezvani M, Haroun RR, et al. (2017) Gestational trophoblastic disease: clinical and imaging features. Radiographics; 37: 681-700.CrossRefPubMed
56.
go back to reference Stenman UH, Alfthan H, Hotakainen K. (2004) Human chorionic gonadotropin in cancer. Clin Biochem; 37:549-561.CrossRefPubMed Stenman UH, Alfthan H, Hotakainen K. (2004) Human chorionic gonadotropin in cancer. Clin Biochem; 37:549-561.CrossRefPubMed
57.
58.
go back to reference Shimomura T. (2005) Sarcomatoid renal cell carcinoma with a chromophobe component producing beta-human chorionic gonadotropin. Int J Urol; 12: 835-837.CrossRefPubMed Shimomura T. (2005) Sarcomatoid renal cell carcinoma with a chromophobe component producing beta-human chorionic gonadotropin. Int J Urol; 12: 835-837.CrossRefPubMed
59.
go back to reference Rukundo J, Ntasumbumuyange D, Small M, Rulisa S, Bazzett-Matabele L. (2017) Theca lutein cysts in the setting of primary hypothyroidism. Ultrasound in Obstetrics and Gynecology; 50: EP25.13. Rukundo J, Ntasumbumuyange D, Small M, Rulisa S, Bazzett-Matabele L. (2017) Theca lutein cysts in the setting of primary hypothyroidism. Ultrasound in Obstetrics and Gynecology; 50: EP25.13.
60.
go back to reference Jung BG, Kim H. (2001) Severe spontaneous ovarian hyperstimulation syndrome with MR findings. J Comput Assist Tomogr; 25: 215-217.CrossRefPubMed Jung BG, Kim H. (2001) Severe spontaneous ovarian hyperstimulation syndrome with MR findings. J Comput Assist Tomogr; 25: 215-217.CrossRefPubMed
61.
go back to reference Woodward PJ, Sohaey R, Mezzetti TP. (2001) Endometriosis: radiologic-pathologic correlation. Radiographics; 21: 193-216.CrossRefPubMed Woodward PJ, Sohaey R, Mezzetti TP. (2001) Endometriosis: radiologic-pathologic correlation. Radiographics; 21: 193-216.CrossRefPubMed
63.
go back to reference Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP. (2013) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology; 271:126-132.CrossRefPubMed Corwin MT, Gerscovich EO, Lamba R, Wilson M, McGahan JP. (2013) Differentiation of ovarian endometriomas from hemorrhagic cysts at MR imaging: utility of the T2 dark spot sign. Radiology; 271:126-132.CrossRefPubMed
64.
go back to reference McDermott S, Oei TN, Iyer VR, Lee SI. (2012) MR imaging of malignancies arising in endometriomas and extra-ovarian endometriosis. Radiographics; 32:845-863.CrossRefPubMed McDermott S, Oei TN, Iyer VR, Lee SI. (2012) MR imaging of malignancies arising in endometriomas and extra-ovarian endometriosis. Radiographics; 32:845-863.CrossRefPubMed
65.
go back to reference Levine D, Brown DL, Andreotti RF, et al. (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology; 256:943-954.CrossRefPubMed Levine D, Brown DL, Andreotti RF, et al. (2010) Management of asymptomatic ovarian and other adnexal cysts imaged at US: Society of Radiologists in Ultrasound consensus conference statement. Radiology; 256:943-954.CrossRefPubMed
66.
go back to reference Outware EK, Wagner BJ, Mannion C, et al. (1998) Sex cord-stromal and steroid cell tumors of the ovary. Radiographics; 18: 1523-1546.CrossRef Outware EK, Wagner BJ, Mannion C, et al. (1998) Sex cord-stromal and steroid cell tumors of the ovary. Radiographics; 18: 1523-1546.CrossRef
67.
go back to reference Jung SE, Rha SE, Lee JM, et al. (2005) CT and MRI findings of sex cord-stromal tumor of the ovary. Am J Roentgenol; 185:207-215.CrossRef Jung SE, Rha SE, Lee JM, et al. (2005) CT and MRI findings of sex cord-stromal tumor of the ovary. Am J Roentgenol; 185:207-215.CrossRef
68.
go back to reference Horta M, Cunha TM, Marques RC, Felix A. (2014) Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review. Radiology Case; 8:30-41.CrossRefPubMed Horta M, Cunha TM, Marques RC, Felix A. (2014) Ovarian Sertoli-Leydig cell tumor with heterologous elements of gastrointestinal type associated with elevated serum alpha-fetoprotein level: an unusual case and literature review. Radiology Case; 8:30-41.CrossRefPubMed
69.
go back to reference McGill FM, Ritter DB, Rickard CS, et al. (1999) Krukenberg tumors: can management be improved? Gynecol Obstet Invest; 48:61-65.CrossRefPubMed McGill FM, Ritter DB, Rickard CS, et al. (1999) Krukenberg tumors: can management be improved? Gynecol Obstet Invest; 48:61-65.CrossRefPubMed
71.
go back to reference Syed FA, Oursler MJ, Hefferanm TE, et al. (2008) Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int; 19:1323-1330.CrossRefPubMedPubMedCentral Syed FA, Oursler MJ, Hefferanm TE, et al. (2008) Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women. Osteoporos Int; 19:1323-1330.CrossRefPubMedPubMedCentral
Metadata
Title
Abdominal and pelvic imaging findings associated with sex hormone abnormalities
Authors
Nicole Kurzbard-Roach
Priyanka Jha
Liina Poder
Christine Menias
Publication date
01-03-2019
Publisher
Springer US
Published in
Abdominal Radiology / Issue 3/2019
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-018-1844-1

Other articles of this Issue 3/2019

Abdominal Radiology 3/2019 Go to the issue